DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
271	強直性脊椎炎	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00247962 (ClinicalTrials.gov)	December 2005	31/10/2005	Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis	A Randomized, Double-Blind Study Evaluating the Safety and Efficacy of Etanercept and Sulphasalazine in Subjects With Ankylosing Spondylitis	Ankylosing Spondylitis	Drug: etanercept;Drug: sulphasalazine (SSZ)	Wyeth is now a wholly owned subsidiary of Pfizer	NULL	Completed	18 Years	N/A	All	566	Phase 4	Australia;Austria;China;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Qatar;Saudi Arabia;Spain;Sweden;United Kingdom;Greece;Portugal;Switzerland

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00247962
(ClinicalTrials.gov)

December 2005

31/10/2005

Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis

A Randomized, Double-Blind Study Evaluating the Safety and Efficacy of Etanercept and Sulphasalazine in Subjects With Ankylosing Spondylitis

Ankylosing Spondylitis

Drug: etanercept;Drug: sulphasalazine (SSZ)

Wyeth is now a wholly owned subsidiary of Pfizer

NULL

Completed

18 Years

N/A

All

566

Phase 4

Australia;Austria;China;Czech Republic;Denmark;Finland;France;Germany;Hungary;Ireland;Italy;Netherlands;Poland;Qatar;Saudi Arabia;Spain;Sweden;United Kingdom;Greece;Portugal;Switzerland